# Elevated Antibacterial Activity of a Polygalacturonic + Caprylic Acids Wound Ointment Compared with Hypochlorous Acid in a Three-Dimensional Wound Biofilm Model

**Authors:** Bahgat Gerges, Joel Rosenblatt, Y-Lan Truong, Ying Jiang, Issam Raad

PMC · DOI: 10.3390/pathogens15020188 · 2026-02-08

## TL;DR

A new plant-based wound ointment is more effective than hypochlorous acid at killing antibiotic-resistant bacteria in wound biofilms.

## Contribution

A novel combination of polygalacturonic and caprylic acids shows superior antibacterial activity against wound biofilms compared to hypochlorous acid.

## Key findings

- PG + CAP significantly reduced viable organisms compared to HOCl against MRSA, MDR P. aeruginosa, and other resistant bacteria.
- The combination was highly effective against biofilms of all tested resistant bacterial isolates.
- PG + CAP is a promising alternative for treating chronic wounds contaminated with bacterial biofilms.

## Abstract

Bacterial biofilms play a major role in delayed wound-healing and in the development of chronic, non-healing wounds. Natural, plant-based agents, which can eradicate bacterial biofilms, are alternatives to antibiotics and antiseptics in the treatment of bacterially contaminated wounds. Bacterial wound biofilms are three-dimensional and complex microbial communities. Therefore, in this study, we used a three-dimensional fibrin-gel wound biofilm (FGWB) model to compare a commonly used natural agent in wound care, hypochlorous acid (HOCl), to a combination of two natural plant-based agents, polygalacturonic acid (PG) and caprylic acid (CAP) (PG + CAP), for their abilities to eradicate resistant bacterial biofilms of common wound pathogens methicillin resistant Staphylococcus aureus (MRSA), multi-drug resistant (MDR) Pseudomonas aeruginosa, metallo β-Lactamase Escherichia coli, and Streptococcus pyogenes. PG + CAP produced a significantly greater reduction in viable organisms when compared to HOCL (p ≤ 0.05) against all tested bacterial isolates. PG + CAP was highly effective against biofilms of all resistant bacterial isolates and is a promising option that merits further study for treating chronic wounds contaminated with bacterial biofilms.

## Linked entities

- **Chemicals:** caprylic acid (PubChem CID 379), hypochlorous acid (PubChem CID 24341)
- **Species:** Staphylococcus aureus (taxon 1280), Pseudomonas aeruginosa (taxon 287), Escherichia coli (taxon 562), Streptococcus pyogenes (taxon 1314)

## Full-text entities

- **Genes:** FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, beta-Lactamase [NCBI Gene 7872529], F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** Cancer (MESH:D009369), inflammation (MESH:D007249), Chronic wounds (MESH:D014947), Cytotoxicity (MESH:D064420), infection (MESH:D007239), MRSA (MESH:D013203), CAP (MESH:D011015)
- **Chemicals:** HOCL (MESH:D006997), pectin (MESH:D010368), gold (MESH:D006046), methicillin (MESH:D008712), calcium chloride (MESH:D002122), nucleotides (MESH:D009711), carbapenem (MESH:D015780), water (MESH:D014867), PG (MESH:C003181), glycerol (MESH:D005990), CAP (MESH:C031492), CAS #10035-04-8 (-), lipid (MESH:D008055)
- **Species:** Pseudomonas aeruginosa (species) [taxon 287], Malus domestica (apple, species) [taxon 3750], Escherichia coli (E. coli, species) [taxon 562], Enterobacterales (order) [taxon 91347], Streptococcus pyogenes (species) [taxon 1314], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943488/full.md

---
Source: https://tomesphere.com/paper/PMC12943488